Carlsbad-based Yulex Corporation said yesterday that it has raised $8M in a Series C funding. The company is developing an alternative to latex for latex allergy sufferers in the medical field. The funding came from Argonaut Private Equity. Total funding in the firm now totals $12.5M. Yulex is developing an alternative latex material which does not trigger latex allergies, an issue with medical workers and others who frequently use rubber globes. More information »